Spatiotemporal Omics-Refining the landscape of precision medicine

Abstract

Current streamline of precision medicine uses histomorphological and molecular information to indicate individual phenotypes and genotypes to achieve optimal outcome of treatment. The knowledge of detected mutations and alteration can hardly describe molecular interaction and biological process which can finally be manifested as a disease. With molecular diagnosis revising the modalities of disease, there is a trend in precision medicine to apply multiomic and multidimensional information to decode tumors, regarding heterogeneity, pathogenesis, prognosis, etc. Emerging state-of-art spatiotemporal omics provides a novel vision for in discovering clinicopathogenesis associated findings, some of which show a promising potential to be translated to facilitate clinical practice. Here, we summarize the available spatiotemporal omic technologies and algorithms, highlight the novel scientific findings and explore potential applications in the clinical scenario. Spatiotemporal omics present the ability to provide impetus to rewrite clinical pathology and to answer outstanding clinical questions. This review emphasizes the novel vision of spatiotemporal omics to refine the landscape of precision medicine in the clinic.

Keywords

spatiotemporal omics / precision medicine / pathomechanism of disease / spatial algorithms / technologies of spatial omics

References

[1] RobertC. A decade of immune-checkpoint inhibitors in cancer therapy. Nat Commun 2020;11:3801.

[2] KumarV, AbbasAK, AsterJC. Robbins and Cotran Pathologic Basis of Disease. 9th edn. Philadelphia, PA: Elsevier/Saunders, 2015.

[3] Dagogo-JackI, ShawAT, ShawAT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 2018;15:81–94.

[4] GartnerLP. Textbook of Histology. 5th edn. Philadelphia, PA: Elsevier, 2021.

[5] ZhangL, ChenD, SongD, et al. Clinical and translational values of spatial transcriptomics. Signal Transduct Targeted Ther 2022;7:111.

[6] LewisSM, Asselin-Labat ML, NguyenQ, et al. Spatial omics and multiplexed imaging to explore cancer biology. Nat Methods 2021;18:997–1012.

[7] WangM, HuQ, LvT, et al. High-resolution 3D spatiotemporal transcriptomic maps of developing Drosophila embryos and larvae. Dev Cell 2022;57:1271–83.e4.

[8] ChenJ, SuoS, TamPP, et al. Spatial transcriptomic analysis of cryosectioned tissue samples with Geo-seq. Nat Protoc 2017;12:566–80.

[9] MoffittJR, HaoJ, WangG, et al. High-throughput single-cell gene-expression profiling with multiplexed error-robust fluorescence in situ hybridization. Proc Natl Acad Sci USA 2016;113:11046–51.

[10] SalmenF, StahlPL, MollbrinkA, et al. Barcoded solid-phase RNA capture for Spatial Transcriptomics profiling in mammalian tissue sections. Nat Protoc 2018;13:2501–34.

[11] KeR, Mignardi M, PacureanuA, et al. In situ sequencing for RNA analysis in preserved tissue and cells. Nat Methods 2013;10:857–60.

[12] LiaoJ, LuX, ShaoX, et al. Uncovering an organ’s molecular architecture at single-cell resolution by spatially resolved transcriptomics. Trends Biotechnol 2021;39:43–58.

[13] MoffittJR, Lundberg E, HeynH. The emerging landscape of spatial profiling technologies. Nat Rev Genet 2022;23:741–59.

[14] HaoY, HaoS, Andersen-NissenE, et al. Integrated analysis of multimodal single-cell data. Cell 2021;184:3573–87.e29.

[15] BlackS, Phillips D, HickeyJW, et al. CODEX multiplexed tissue imaging with DNA-conjugated antibodies. Nat Protoc 2021;16:3802–35.

[16] JhaveriN, Nikulina N, ZongH, et al. Abstract 3877: deep ultrahigh- plex spatial phenotyping of human cancer tissues. Cancer Res 2022;82:3877.

[17] ChengY, Burrack RM, LiQ. Spatially resolved and highly complexed protein and RNA detection by combining CODEX with RNAscope in situ hybridization. bioRxiv 2022.02.10.479971, 2022.

[18] HeS, BhattR, BrownC, et al. High-plex multiomic analysis in FFPE at subcellular level by spatial molecular imaging. bioRxiv 2021.11.03.467020, 2022.

[19] GiesenC, WangHA, SchapiroD, et al. Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry. Nat Methods 2014;11:417–22.

[20] KerenL, BosseM, MarquezD, et al. A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging. Cell 2018;174:1373–87.e19.

[21] SchulzD, Zanotelli VRT, FischerJR, et al. Simultaneous multiplexed imaging of mRNA and proteins with subcellular resolution in breast cancer tissue samples by mass cytometry. Cell Syst 2018;6:25–36.e5.

[22] LewisSM, Asselin-Labat ML. Spatial omics and multiplexed imaging to explore cancer biology. Nat Methods 2021;18:997–1012.

[23] ChenA, LiaoS, ChengM, et al. Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays. Cell 2022;185:1777–92.e21.

[24] VickovicS, Lotstedt B, KlughammerJ, et al. SM-Omics is an automated platform for high-throughput spatial multi-omics. Nat Commun 2022;13:795.

[25] Ben-ChetritN, NiuX, SwettAD, et al. Integrated protein and transcriptome high-throughput spatial profiling. bioRxiv 2022.03.15.484516, 2022.

[26] ChewJ, Uytingco C, AnaparthyN, et al. Tumor microenvironment characterization using a spatial multiomic assay to simultaneously profile protein and gene expression in FFPE tumors. FASEB J 2022;36.

[27] LiuY, YangM, DengY, et al. High-spatial-resolution multi-omics sequencing via deterministic barcoding in tissue. Cell 2020;183:1665–81.e18.

[28] LiuY, DiStasio M, SuG, et al. Spatial-CITE-seq: spatially resolved high-plex protein and whole transcriptome co-mapping. bioRxiv 2022.04.01.486788, 2022.

[29] DengY, Bartosovic M, MaS, et al. Spatial profiling of chromatin accessibility in mouse and human tissues. Nature 2022;609:375–83.

[30] DengY, Bartosovic M, KukanjaP, et al. Spatial-CUT&Tag: spatially resolved chromatin modification profiling at the cellular level. Science 2022;375:681–6.

[31] NichterwitzS, ChenG, Aguila BenitezJ, et al. Laser capture microscopy coupled with Smart-seq2 for precise spatial transcriptomic profiling. Nat Commun 2016;7:12139.

[32] EllisP, MooreL, SandersMA, et al. Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing. Nat Protoc 2021;16:841–71.

[33] LiottaLA, Pappalardo PA, CarpinoA, et al. Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicine. Expert Rev Proteomics 2021;18:845–61.

[34] ThorntonCA, Mulqueen RM, TorkenczyKA, et al. Spatially mapped single-cell chromatin accessibility. Nat Commun 2021;12:1274.

[35] MerrittCR, OngGT, ChurchSE, et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat Biotechnol 2020;38:586–99.

[36] Jerby-ArnonL, NeftelC, ShoreME, et al. Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma. Nat Med 2021;27:289–300.

[37] DesaiN, NeyazA, SzabolcsA, et al. Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection. Nat Commun 2020;11:6319.

[38] ChoCS, XiJ, SiY, et al. Microscopic examination of spatial transcriptome using Seq-Scope. Cell 2021;184:3559–72.e22.

[39] FuX, SunL, ChenJY, et al. Continuous polony gels for tissue mapping with high resolution and RNA capture efficiency. bioRxiv 2021.03.17.435795, 2021.

[40] LiuC, LiR, LiY, et al. Spatiotemporal mapping of gene expression landscapes and developmental trajectories during zebrafish embryogenesis. Dev Cell 2022;57:1284–1298.e5.

[41] MantriM, Scuderi GJ, Abedini-NassabR, et al. Spatiotemporal single- cell RNA sequencing of developing chicken hearts identifies interplay between cellular differentiation and morphogenesis. Nat Commun 2021;12:1771.

[42] Ben-MosheS, VegT, MancoR, et al. The spatiotemporal program of zonal liver regeneration following acute injury. Cell Stem Cell 2022;29:973–89.e10.

[43] ZhaoE, StoneMR, RenX, et al. Spatial transcriptomics at subspot resolution with BayesSpace. Nat Biotechnol 2021;39:1375–84.

[44] FuH, XuH, ChongK, et al. Unsupervised spatially embedded deep representation of spatial transcriptomics. bioRxiv 2021.06.15.448542, 2021.

[45] HuJ, LiX, ColemanK, et al. SpaGCN: integrating gene expression, spatial location and histology to identify spatial domains and spatially variable genes by graph convolutional network. Nat Methods 2021;18:1342–51.

[46] CableDM, MurrayE, ZouLS, et al. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol 2022;40:517–26.

[47] HirzT, MeiS, SarkarH, et al. Integrated single-cell and spatial transcriptomic analyses unravel the heterogeneity of the prostate tumor microenvironment. 2022.

[48] KleshchevnikovV, Shmatko A, DannE, et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nat Biotechnol 2022;40:661–71.

[49] LopezR, LiB, Keren-ShaulH, et al. Multi-resolution deconvolution of spatial transcriptomics data reveals continuous patterns of inflammation. bioRxiv 2021.05.10.443517, 2021.

[50] BiancalaniT, ScaliaG, BuffoniL, et al. Deep learning and alignment of spatially resolved single-cell transcriptomes with Tangram. Nat Methods 2021;18:1352–62.

[51] La MannoG, Siletti K, FurlanA, et al. Molecular architecture of the developing mouse brain. Nature 2021;596:92–6.

[52] WeiR, HeS, BaiS, et al. Spatial charting of single-cell transcriptomes in tissues. Nat Biotechnol 2022;40:1190–9.

[53] BaeS, NaKJ, KohJ, et al. CellDART: cell type inference by domain adaptation of single-cell and spatial transcriptomic data. Nucleic Acids Res 2022;50:e57.

[54] ParkJ-B, ChoiJ-Y, ChoiH, et al. Spatial transcriptomics-based identification of molecular markers for nanomedicine distribution in tumor tissue. bioRxiv 2022.03.02.482584, 2022.

[55] XuY, McCordRP, McCordRP. CoSTA: unsupervised convolutional neural network learning for spatial transcriptomics analysis. BMC Bioinf 2021;22:397.

[56] DeTomasoD, YosefN, YosefN. Hotspot identifies informative gene modules across modalities of single-cell genomics. Cell Syst 2021;12:446–56.e9.

[57] YangD, JonesMG, NaranjoS, et al. Lineage recording reveals the phylodynamics, plasticity and paths of tumor evolution. 2021.

[58] ChowdhuryS, Ferri-Borgogno S, YangP, et al. Learning directed acyclic graphs for ligands and receptors based on spatially resolved transcriptomic analysis of ovarian cancer. 2021.

[59] EfremovaM, Vento-Tormo M, TeichmannSA, et al. CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes. Nat Protoc 2020;15:1484–506.

[60] PallaG, Spitzer H, KleinM, et al. Squidpy: a scalable framework for spatial omics analysis. Nat Methods 2022;19:171–8.

[61] TureiD, Valdeolivas A, GulL, et al. Integrated intra- and intercellular signaling knowledge for multicellular omics analysis. Mol Syst Biol 2021;17:e9923.

[62] ZhouL, WenR, YuG, et al. Spatial transcriptomic revealed intratumor heterogeneity and cancer stem cell enrichment in colorectal cancer metastasis. 2022.

[63] ChanJM, Quintanal-Villalonga A, GaoVR, et al. Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer. Cancer Cell 2021;39:1479–1496.e18.

[64] TrapnellC, Cacchiarelli D, GrimsbyJ, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol 2014;32:381–6.

[65] WolfFA, HameyFK, PlassM, et al. PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells. Genome Biol 2019;20:59.

[66] StreetK, RissoD, FletcherRB, et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genom 2018;19:477.

[67] La MannoG, Soldatov R, ZeiselA, et al. RNA velocity of single cells. Nature 2018;560:494–8.

[68] BergenV, LangeM, PeidliS, et al. Generalizing RNA velocity to transient cell states through dynamical modeling. Nat Biotechnol 2020;38:1408–14.

[69] QiuX, ZhangY, Martin-RufinoJD, et al. Mapping transcriptomic vector fields of single cells. Cell 2022;185:690–711.e45.

[70] QuinnJJ, JonesMG, OkimotoRA, et al. Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts. Science 2021;371:eabc1944.

[71] Figueres-OnateM, Sanchez-Gonzalez R, Lopez-MascaraqueL. Deciphering neural heterogeneity through cell lineage tracing. Cell Mol Life Sci 2021;78:1971–82.

[72] MatsushitaY, OnoW, OnoN. Synergy of single-cell sequencing analyses and in vivo lineage-tracing approaches: a new opportunity for stem cell biology. Biocell 2022;46:1157–62.

[73] ChenC, LiaoY, PengG. Connecting past and present: single-cell lineage tracing. Protein Cell 2022;13:790–807.

[74] Sautès-FridmanC, Petitprez F, CalderaroJ, et al. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer 2019;19:307–25.

[75] Dieu-NosjeanMC, GocJ, GiraldoNA, et al. Tertiary lymphoid structures in cancer and beyond. Trends Immunol 2014;35:571–80.

[76] PitzalisC, JonesGW, BombardieriM, et al. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol 2014;14:447–62.

[77] AnderssonA, Larsson L, StenbeckL, et al. Spatial deconvolution of HER2-positive breast cancer delineates tumor-associated cell type interactions. Nat Commun 2021;12:6012.

[78] MeylanM, Petitprez F, BechtE, et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 2022;55:527–541.e5.

[79] WuR, GuoW, QiuX, et al. Comprehensive analysis of spatial architecture in primary liver cancer. Sci Adv 2021;7:eabg3750.

[80] WuL, YanJ, BaiY, et al. Spatially-resolved transcriptomics analyses of invasive fronts in solid tumors. bioRxiv 2021.10.21.465135, 2021.

[81] JiAL, RubinAJ, ThraneK, et al. Multimodal analysis of composition and spatial architecture in human squamous cell carcinoma. Cell 2020;182:497–514.e22.

[82] OmbratoL, NolanE, KurelacI, et al. Metastatic-niche labelling reveals parenchymal cells with stem features. Nature 2019;572:603–8.

[83] BarkleyD, Moncada R, PourM, et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat Genet 2022;54:1192–201.

[84] DanenbergE, Bardwell H, ZanotelliVRT, et al. Breast tumor microenvironment structures are associated with genomic features and clinical outcome. Nat Genet 2022;54:660–9.

[85] Cui ZhouD, Jayasinghe RG, ChenS, et al. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Nat Genet 2022;54:1390–405.

[86] ChenWT, LuA, CraessaertsK, et al. Spatial transcriptomics and in situ sequencing to study Alzheimer’s disease. Cell 2020;182:976–91.e19.

[87] RendeiroAF, Ravichandran H, BramY, et al. The spatial landscape of lung pathology during COVID-19 progression. Nature 2021;593:564–9.

[88] KuppeC, Ramirez Flores RO, LiZ, et al. Spatial multi-omic map of human myocardial infarction. Nature 2022;608:766–77.

[89] ChungBK, OgaardJ, ReimsHM, et al. Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis. Hepatol Commun 2022;6:2538–50.

[90] PengL, JinX, LiBY, et al. Integrating single-cell RNA sequencing with spatial transcriptomics reveals immune landscape for interstitial cystitis. Signal Transduct Target Ther 2022;7:161.

[91] VickovicS, Eraslan G, SalménF, et al. High-definition spatial transcriptomics for in situ tissue profiling. Nat Methods 2019;16:987–90.

[92] AkbarM, MacDonald L, CroweLAN, et al. Single cell and spatial transcriptomics in human tendon disease indicate dysregulated immune homeostasis. Ann Rheum Dis 2021;80:1494–7.

[93] RaoA, Barkley D, FrancaGS, et al. Exploring tissue architecture using spatial transcriptomics. Nature 2021;596:211–20.

[94] BourzacK. Diagnosis: early warning system. Nature 2014;513:S4–6.

[95] BaronM, TagoreM, HunterMV, et al. The stress-like cancer cell state is a consistent component of tumorigenesis. Cell Syst 2020;11:536–546.e7.

[96] WangJ, HuangTY, HouY, et al. Epigenomic landscape and 3D genome structure in pediatric high-grade glioma. Sci Adv 2021;7:eabg4126.

[97] ManiatisS, Äijö T, VickovicS, et al. Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis. Science 2019;364:89–93.

[98] YoosufN, Navarro JF, SalménF, et al. Identification and transfer of spatial transcriptomics signatures for cancer diagnosis. Breast Cancer Res 2020;22:1–10.

[99] YersalO, Barutca S, BarutcaS. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol 2014;5:412–24.

[100] MosesL, Pachter L. Museum of spatial transcriptomics. Nat Methods 2022;19:534–46.

[101] MaynardKR, JaffeAE, MartinowichK. Spatial transcriptomics: putting genome-wide expression on the map. Neuropsychopharmacology 2020;45:232–3.

[102] LiuS, Kurzrock R, KurzrockR. Toxicity of targeted therapy: implications for response and impact of genetic polymorphisms. Cancer Treat Rev 2014;40:883–91.

[103] HaslamA, KimMS, PrasadV. Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020. Ann Oncol 2021;32:926–32.

[104] ZhouX, YaoZ, YangH, et al. Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis. BMC Med 2020;18:87.

[105] DoroshowDB, Sanmamed MF, HastingsK, et al. Immunotherapy in non–small cell lung cancer: facts and hopes. Clin Cancer Res 2019;25:4592–602.

[106] SchoenfeldAJ, Hellmann MD, HellmannMD. Acquired resistance to immune checkpoint inhibitors. Cancer Cell 2020;37:443–55.

[107] QiJ, SunH, ZhangY, et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun 2022;13:1742.

[108] ZugazagoitiaJ, GuptaS, LiuY, et al. Biomarkers associated with beneficial PD-1 checkpoint blockade in non–small cell lung cancer (NSCLC) identified using high-Plex digital spatial profiling. Clin Cancer Res 2020;26:4360–8.

[109] ColwellJ. Is PD-L1 expression a biomarker of response? Cancer Discov 2015;5:1232.

[110] FaresJ, FaresMY, KhachfeHH, et al. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 2020;5:28.

[111] ZlobecI, BergerMD, LugliA. Tumour budding and its clinical implications in gastrointestinal cancers. Br J Cancer 2020;123:700–8.

[112] SchurchCM, BhateSS, BarlowGL, et al. Coordinated cellular neighborhoods orchestrate antitumoral immunity at the colorectal cancer invasive front. Cell 2020;182:1341–59.e19.

[113] JamiesonNB, Legrini A, LeslieH, et al. High-plex proteomic prognostic marker discovery for patients with pancreatic cancer adenocarcinoma using digital spatial profiling. J Clin Oncol 2022;40:611.

[114] WangY, Kartasalo K, WeitzP, et al. Predicting molecular phenotypes from histopathology images: a transcriptome-wide expression–morphology analysis in breast cancer. Cancer Res 2021;81:5115–26.

[115] LopesMT. 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 2017;134:521–35.

[116] Rodriguez-HernandezI, Maiques O, KohlhammerL, et al. WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion. Nat Commun 2020;11:5315.

[117] TomeME, Johnson DB, RimszaLM, et al. A redox signature score identifies diffuse large B-cell lymphoma patients with a poor prognosis. Blood 2005;106:3594–601.

[118] AlmetAA, CangZ, JinS, et al. The landscape of cell–cell communication through single-cell transcriptomics. Curr Opin Syst Biol 2021;26:12–23.

RIGHTS & PERMISSIONS

The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.